To provide proof for an unimpaired activity of resminostat in the course of MeV-based infections of human hepatoma cells, we determined expression levels of zinc finger protein 64 (zfp64), which functions as a well-established surrogate parameter for the pharmacological activity of resminostat, in absence/presence of MeV-SCD. Here, SCD is linked to hepatocellular carcinoma.